Armatus Bio
Signal active
Organization
Contact Information
Overview
Armatus Bio is a new precision pharmaceutical firm based on genetic science and bioengineering. Precision therapeutics are being developed with dynamic thinking and rigorous processes to deliver life-saving drugs more effectively and efficiently than ever before. They believe that engineering will be a major catalyst in moving precision treatments from research and development to mainstream care. To stimulate disruptive therapeutic innovation, they are using advanced engineering methodologies to create synergistic technologies.
About
Industries
Biotechnology, Biopharma, Health Diagnostics
Founded
Invalid date
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Armatus Bio headquartered in United States, North America, operates in the Biotechnology, Biopharma, Health Diagnostics sector. With a team of 1-10 employees, Armatus Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Armatus Bio, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$0
Details
1
Armatus Bio has raised a total of $0 in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed |
Investors
Armatus Bio is funded by 3 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Thomas W. Dubensky | - | FUNDING ROUND - Thomas W. Dubensky | undefined |
| Armatus Bio | - | FUNDING ROUND - Armatus Bio | undefined |
| CMTA | - | FUNDING ROUND - CMTA | undefined |
Recent Activity
There is no recent news or activity for this profile.